{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:15:42Z","timestamp":1790813742277,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1681\/asn.2015020124","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T21:11:19Z","timestamp":1436994679000},"page":"887-893","source":"Crossref","is-referenced-by-count":126,"title":["APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline"],"prefix":"10.1681","volume":"27","author":[{"given":"Carmen A.","family":"Peralta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Bibbins-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Fornage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20230208","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States.","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"R2-25-20230208","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","article-title":"Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.","volume":"14","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R3-25-20230208","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2215\/CJN.06450611","article-title":"Racial differences in the incidence of chronic kidney disease.","volume":"7","author":"Muntner","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-25-20230208","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1681\/ASN.2010090960","article-title":"Racial and ethnic differences in kidney function decline among persons without chronic kidney disease.","volume":"22","author":"Peralta","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R5-25-20230208","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.ajkd.2013.01.012","article-title":"Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study.","volume":"62","author":"Peralta","year":"2013","journal-title":"American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation"},{"key":"R6-25-20230208","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease.","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R7-25-20230208","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans.","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"R8-25-20230208","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney Int"},{"key":"R9-25-20230208","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R10-25-20230208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"R11-25-20230208","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease.","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"R12-25-20230208","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans.","volume":"24","author":"Foster","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R13-25-20230208","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease.","volume":"22","author":"Madhavan","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R14-25-20230208","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1681\/ASN.2012040347","article-title":"Cost-effectiveness of screening for microalbuminuria among African Americans.","volume":"23","author":"Hoerger","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R15-25-20230208","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","article-title":"CARDIA: study design, recruitment, and some characteristics of the examined subjects.","volume":"41","author":"Friedman","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"R16-25-20230208","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C.","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"R17-25-20230208","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/hmg\/ddr118","article-title":"The MYH9\/APOL1 region and chronic kidney disease in European-Americans.","volume":"20","author":"O\u2019Seaghdha","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R18-25-20230208","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations.","volume":"21","author":"Limou","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"R19-25-20230208","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1371\/journal.pgen.0020190","article-title":"Population structure and eigenanalysis.","volume":"2","author":"Patterson","year":"2006","journal-title":"PLoS Genet"},{"key":"R20-25-20230208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.socscimed.2013.07.031","article-title":"Race, life course socioeconomic position, racial discrimination, depressive symptoms and self-rated health.","volume":"97","author":"Hudson","year":"2013","journal-title":"Soc Sci Med"},{"key":"R21-25-20230208","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/aje\/kwp015","article-title":"Estimating the effects of potential public health interventions on population disease burden: a step-by-step illustration of causal inference methods.","volume":"169","author":"Ahern","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R22-25-20230208","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2006080872","article-title":"Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.","volume":"18","author":"Perkins","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R23-25-20230208","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1523-1755.2002.00299.x","article-title":"Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency.","volume":"61","author":"Hsu","year":"2002","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201603000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:45Z","timestamp":1786130805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201603000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2015020124","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}